Patents by Inventor Michael Piepenbrink

Michael Piepenbrink has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-influenza neuraminidase monoclonal antibodies and uses thereof
    Patent number: 11958895
    Abstract: The present invention relates to broadly neutralizing anti-influenza monoclonal antibodies or antigen-binding fragments thereof. The present invention further relates to therapeutic uses of the isolated antibody or the antigen-binding fragment thereof.
    Type: Grant
    Filed: May 2, 2019
    Date of Patent: April 16, 2024
    Assignee: University of Rochester
    Inventors: James J. Kobie, Luis Martinez-Sobrido, Michael Piepenbrink, Aitor Nogales
  • MONOCLONAL ANTIBODIES AGAINST THE HEMAGGLUTININ (HA) AND NEURAMINIDASE (NA) OF INFLUENZA H3N2 VIRUSES
    Publication number: 20230107644
    Abstract: The present disclosure relates to neutralizing anti-influenza monoclonal antibodies. The disclosure further relates to therapeutic uses of the isolated antibody. The antibodies are either directed against Hemagglutinin (HA) and Neuraminidase (NA) of Influenza H3N2.
    Type: Application
    Filed: March 25, 2021
    Publication date: April 6, 2023
    Applicant: University of Rochester
    Inventors: James J. Kobie, Luis Martinez-Sobrido, Michael Piepenbrink, Aitor Nogales
  • Broadly neutralizing anti-influenza human monoclonal antibody and uses thereof
    Patent number: 11168129
    Abstract: The present invention relates to broadly neutralizing anti-influenza monoclonal antibodies or antigen-binding fragments thereof. The present invention further relates to therapeutic uses of the isolated antibody or the antigen-binding fragment thereof.
    Type: Grant
    Filed: May 10, 2018
    Date of Patent: November 9, 2021
    Assignee: University of Rochester
    Inventors: James J. Kobie, Michael Piepenbrink, Michael Keefer, Luis Martinez-Sobrido, Aitor Nogales
  • ANTI-INFLUENZA NEURAMINIDASE MONOCLONAL ANTIBODIES AND USES THEREOF
    Publication number: 20210047389
    Abstract: The present invention relates to broadly neutralizing anti-influenza monoclonal antibodies or antigen-binding fragments thereof. The present invention further relates to therapeutic uses of the isolated antibody or the antigen-binding fragment thereof.
    Type: Application
    Filed: May 2, 2019
    Publication date: February 18, 2021
    Inventors: James J. Kobie, Luis Martinez-Sobrido, Michael Piepenbrink, Aitor Nogales
  • Broadly Neutralizing Anti-Influenza Human Monoclonal Antibody and Uses Thereof
    Publication number: 20200140526
    Abstract: The present invention relates to broadly neutralizing anti-influenza monoclonal antibodies or antigen-binding fragments thereof. The present invention further relates to therapeutic uses of the isolated antibody or the antigen-binding fragment thereof.
    Type: Application
    Filed: May 10, 2018
    Publication date: May 7, 2020
    Applicant: University of Rochester
    Inventors: James J. Kobie, Michael Piepenbrink, Michael Keefer, Luis Martinez-Sobrido, Aitor Nogales